Castlekeep Investment Advisors LLC bought a new position in Exponent, Inc. (NASDAQ:EXPO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,633 shares of the business services provider's stock, valued at approximately $413,000.
A number of other institutional investors have also recently bought and sold shares of EXPO. Private Trust Co. NA boosted its holdings in shares of Exponent by 129.8% in the 4th quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after purchasing an additional 157 shares during the last quarter. Atala Financial Inc acquired a new position in Exponent in the fourth quarter valued at $25,000. Tortoise Investment Management LLC grew its position in Exponent by 76.7% during the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after acquiring an additional 191 shares during the period. Trust Co. of Vermont acquired a new stake in Exponent during the fourth quarter worth about $45,000. Finally, Brown Brothers Harriman & Co. purchased a new position in shares of Exponent in the 4th quarter worth about $50,000. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Exponent
In other Exponent news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now owns 1,800 shares in the company, valued at $154,674. This represents a 49.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.10% of the company's stock.
Exponent Stock Performance
EXPO traded down $0.53 on Friday, reaching $76.67. 203,680 shares of the company's stock were exchanged, compared to its average volume of 242,673. Exponent, Inc. has a twelve month low of $73.37 and a twelve month high of $115.75. The company's 50 day moving average is $79.74 and its 200-day moving average is $88.48. The company has a market cap of $3.89 billion, a price-to-earnings ratio of 36.17 and a beta of 0.95.
Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04. The company had revenue of $137.44 million during the quarter, compared to the consensus estimate of $134.63 million. Exponent had a net margin of 19.52% and a return on equity of 27.27%. Exponent's revenue for the quarter was up .2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.59 earnings per share. Sell-side analysts forecast that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.57%. The ex-dividend date is Friday, June 6th. Exponent's payout ratio is 58.54%.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.